How endothelial cell organo-specificity mediates circulating cell homing

Archivum Immunologiae et Therapiae Experimentalis

Volumn 51, Issue 2, 2003, Pages 81-89

  Kieda, Claudine ^a  

^a CENTRE DE BIOPHYSIQUE MOLÉCULAIRE   (France)

Author keywords

Adhesion; Chemokines; Endothelial cell; Lectins glycoconjugates

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 7; LECTIN; MUCIN; PADGEM PROTEIN;

ADOPTIVE IMMUNOTHERAPY; ANGIOGENESIS; ANTIBODY SPECIFICITY; BINDING AFFINITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL PROLIFERATION; CELL SPECIFICITY; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; DRUG TARGETING; ENDOTHELIUM CELL; GENE THERAPY; INFLAMMATION; LEUKOCYTE ACTIVATION; LIGAND BINDING; METASTASIS; MOLECULAR MECHANICS; MOLECULAR RECOGNITION; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL; TUMOR;

ANIMALS; CELL COMMUNICATION; CELL MOVEMENT; CHEMOKINES; CYTOKINES; ENDOTHELIUM, VASCULAR; GLYCOCONJUGATES; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; ORGAN SPECIFICITY; SIGNAL TRANSDUCTION;

EID: 0037276034     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (122)

1. ACHEN M. G., WILLIAMS R. A., BALDWIN M. E., LAI P., ROUFAIL S., ALITALO K. and STACKER S. A. (2002): The angiogenic and lymphangiogenic factor vascular endothelial growth factor-D exhibits a paracrine mode of action in cancer. Growth Factors, 20, 99-107.
2. ADACHI S., YOSHIDA H., HONDA K., MAKI K., SAIJO K., IKUTA K., SAITO T. and NISHIKAWA S. I. (1998): Essential role of IL-7 receptor α in the formation of Peyer's patch anlage. Int. Immunol., 10, 1-6.
3. ALDERSON M. R., SASSENFELD H. M. and WIDMER M. B. (1990): Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood. J. Exp. Med., 172, 577-587.
4. ALDERSON M. R., TOUGH T. W., ZIEGLER S. F. and GRABSTEIN K. H. (1991): Interleukin 7 induces cytokine secretion and tumoricidal activity by human peripheral blood monocytes. J. Exp. Med., 173, 923-930.
5. AOUDJIT F., POTWOROWSKI E. F. and ST-PIERRE Y. (1998): The metastatic characteristics of murine lymphoma cell lines in vivo are manifested after target organ invasion. Blood, 91, 623-629.
6. ARVILOMMI A. M., SALMI M., KALIMO K. and JALKANEN S. (1996): Lymphocyte binding to vascular endothelium in inflamed skin revisited: a central role for vascular adhesion protein-1 (VAP-1). Eur. J. Immunol., 26, 825-833.
7. AUGUSTIN H. G., BRAUN K., TELEMENAKIS I., MODLICH U. and KUHN W. (1995): Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression. Am. J. Pathol., 147, 339-351.
8. BARGATZE R. F., KURK S., BUTCHER E. C. and JUTILA M. A. (1994): Neutrophils roll on adherent neutrophils bound to cytokine-induced endothelial cells via L-selectin on the rolling cells. J. Exp. Med., 180, 1785-1792.
9. BASTIAS J., WEI M. X., HUYNH R., CHAUBET F., JOZEFONVICZ J. and CREPIN M. (2002): Anti-proliferative and antitumoral activities of a functionalized dextran (CMDBJ) on the 1205 L-U human tumor melanoma cells. Anticancer Res., 22, 1603-1613.
10. BAZAN J. F., BACON K. B., HARDIMAN G., WANG W., SOO K., ROSSI D., GREAVES D. R., ZLOTNIK A. and SCHALL T. J. (1997): A new class of membrane-bound chemokine with a CX3C motif. Nature, 385, 640-644.
11. BEASLEY N. J., PREVO R., BANERJI S., LEEK R. D., MOORE J., VAN TRAPPEN P., COX G., HARRIS A. L. and JACKSON D. G. (2002): Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res., 62, 1315-1320.
12. BERG E. L., GOLDSTEIN L. A., JUTILA M. A., NAKACHE M., PICKER L. J., STREETER P. R., WU N. W., ZHOU D. and BUTCHER E. C. (1989): Homing receptors and vascular addressins: cell adhesion molecules that direct lymphocyte traffic. Immunol. Rev., 108, 5-18.
13. BERG E. L., MAGNANI J., WARNOCK R. A., ROBINSON M. K. and BUTCHER E. C. (1992): Comparison of L-selectin and E-selectin ligand specificities: the L-selectin can bind the E-selectin ligands sialyl Le(x) and sialyl Le(a). Biochem. Biophys. Res. Commun., 184, 1048-1055.
14. BERG E. L., MCEVOY L. M., BERLIN C., BARGATZE R. F. and BUTCHER E. C. (1993): L-selectin-mediated lymphocyte rolling on MAdCAM-1. Nature, 366, 695-698.
15. BERG E. L., MULLOWNEY A. T., ANDREW D. P., GOLDBERG J. E. and BUTCHER E. C. (1998): Complexity and differential expression of carbohydrate epitopes associated with L-selectin recognition of high endothelial venules. Am. J. Pathol., 152, 469-477.
16. BERG E. L., ROBINSON M. K., MANSSON O., BUTCHER E. C. and MAGNANI J. L. (1991): A carbohydrate domain common to both sialyl Le(a) and sialyl Le(X) is recognized by the endothelial cell leukocyte adhesion molecule ELAM-1. J. Biol. Chem., 266, 14869-14872.
17. BERG E. L., YOSHINO T., ROTT L. S., ROBINSON M. K., WARNOCK R. A., KISHIMOTO T. K., PICKER L. J. and BUTCHER E. C. (1991): The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1. J. Exp. Med., 174, 1461-1466.
18. BERLIN C., BARGATZE R. F., CAMPBELL J. J., VON ANDRIAN U. H., SZABO M. C., HASSLEN S. R., NELSON R. D., BERG E. L., ERLANDSEN S. L. and BUTCHER E. C. (1995): Alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell, 80, 413-422.
19. BEVILACQUA M. P., NELSON R. M., MANNORI G. and CECCONI O. (1994): Endothelial-leukocyte adhesion molecules in human disease. Annu. Rev. Med., 45, 361-378.
20. BIZOUARNE N., DENIS V., LEGRAND A., MONSIGNY M. and KIEDA C. (1993): A SV-40 immortalized murine endothelial cell line from peripheral lymph node high endothelium expresses a new alpha-L-fucose binding protein. Biol. Cell, 79, 209-218.
21. BIZOUARNE N., MITTERRAND M., MONSIGNY M. and KIEDA C. (1993): Characterization of membrane sugar-specific receptors in cultured high endothelial cells from mouse peripheral lymph nodes. Biol. Cell, 79, 27-35.
22. BORGHESI L. A., YAMASHITA Y. and KINCADE P. W. (1999): Heparan sulfate proteoglycans mediate interleukin-7-dependent B lymphopoiesis. Blood, 93, 140-148.
23. BRISKIN M., WINSOR-HINES D., SHYJAN A., COCHRAN N., BLOOM S., WILSON J., MCEVOY L. M., BUTCHER E. C., KASSAM N., MACKAY C. R., NEWMAN W. and RINGLER D. J. (1997): Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am. J. Pathol., 151, 97-110.
24. BURGER M. M. (2001): Mechanisms of metastasis. Ther. Umsch., 58, 695-700.
25. BUTCHER E. C. and PICKER L. J. (1996): Lymphocyte homing and homeostasis. Science, 272, 60-66.
26. BUTCHER E. C., WILLIAMS M., YOUNGMAN K., ROTT L. and BRISKIN M. (1999): Lymphocyte trafficking and regional immunity. Adv. Immunol., 72, 209-253.
27. CHIN Y. H., CAI J. P. and Xu X. M. (1991): Tissue-specific homing receptor mediates lymphocyte adhesion to cytokine-stimulated lymph node high endothelial venule cells. Immunology, 74, 478-483.
28. COOPER C. R., BHATIA J. K., MUENCHEN H. J., MCLEAN L., HAYASAKA S., TAYLOR J., PONCZA P. J. and PIENTA K. J. (2002): The regulation of prostate cancer cell adhesion to human bone marrow endothelial cell monolayers by androgen dihydrotestosterone and cytokines. Clin. Exp. Metastasis, 19, 25-33.
29. CUMMINGS R. D. and SMITH D. F. (1992). The selectin family of carbohydrate-binding proteins: structure and importance of carbohydrate ligands for cell adhesion. Bioessays, 14, 849-856.
30. DAVIDOFF A. M., LEARY M. A., NG C. Y. and VANIN E. F. (2001): Gene therapy-mediated expression by tumor cells of the angiogenesis inhibitor flk-1 results in inhibition of neuroblastoma growth in vivo. J. Pediatr. Surg., 36, 30-36.
31. DEININGER M. H., TRAUTMANN K., MEYERMANN R. and SCHLUESENER H. J. (2002). Galectin-3 labeling correlates positively in tumor cells and negatively in endothelial cells with malignancy and poor prognosis in oligodendroglioma patients. Anticancer Res., 22, 1585-1592.
32. DENIS V., DUPUIS P., BIZOUARNE N., DE O SAMPAIO S., HONG L., LEBRET M., MONSIGNY M., NAKACHE M. and KIEDA C. (1996): Selective induction of peripheral and mucosal endothelial cell addressins with peripheral lymph nodes and Peyer's patch cell-conditioned media. J. Leukoc. Biol., 60, 744-752.
33. DIMITROFF C. J., LEE J. Y., RAFII S., FUHLBRIGGE R. C. and SACKSTEIN R. (2001): CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J. Cell Biol., 153, 1277-1286.
34. DUIJVESTIJN A. M., KERKHOVE M., BARGATZE R. F. and BUTCHER E. C. (1987): Lymphoid tissue- and inflammation-specific endothelial cell differentiation defined by monoclonal antibodies. J. Immunol., 138, 713-719.
35. EBNET K., KALDJIAN E. P., ANDERSON A. O. and SHAW S. (1996): Orchestrated information transfer underlying leukocyte endothelial interactions. Annu. Rev. Immunol., 14, 155-177.
36. FIEGER C. B., EMIG-VOLLMER S., PETRI T., GRAFE M., GOHLKE M., DEBUS N., SEMMLER W., TAUBER R. and VOLZ B. (2001): The adhesive properties of recombinant soluble L-selectin are modulated by its glycosylation. Biochim. Biophys. Acta, 1524, 75-85.
37. FONG A. M., ROBINSON L. A., STEEBER D. A., TEDDER T. F., YOSHIE O., IMAI T. and PATEL D. D. (1998): Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J. Exp. Med., 188, 1413-1419.
38. GIRARD J. P. and SPRINGER T. A. (1995): High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol. Today, 16, 449-457.
39. GULUBOVA M. V. (2002): Expression of cell adhesion molecules, their ligands and tumour necrosis factor α in the liver of patients with metastatic gastrointestinal carcinomas. Histochem. J., 34, 67-77.
40. HALLORAN M. M., CARLEY W. W., POLVERINI P. J., HASKELL C. J., PHAN S., ANDERSON B. J., WOODS J. M., CAMPBELL P. L., VOLIN M. V., BACKER A. E. and KOCH A. E. (2000): Ley/H: an endothelial-selective, cytokine-inducible, angiogenic mediator. J. Immunol., 164, 4868-4877.
41. HARALDSEN G., KVALE D., LIEN B., FARSTAD I. N. and BRANDTZAEG P. (1996): Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. J. Immunol., 156, 2558-2565.
42. HASSLEN S. R., VON ANDRIAN U. H., BUTCHER E. C., NELSON R. D. and ERLANDSEN S. L. (1995): Spatial distribution of L-selectin (CD62L) on human lymphocytes and transfected murine L1-2 cells. Histochem. J., 27, 547-554.
43. HEMMERICH S., BUTCHER E. C. and ROSEN S. D. (1994): Sulfation-dependent recognition of high endothelial venules (HEV)-ligands by L-selectin and MECA79, and adhesion-blocking monoclonal antibody. J. Exp. Med., 180, 2219-2226.
44. HORAN P. K. and SLEZAK S. E. (1989): Stable cell membrane labelling. Nature, 340, 167-168.
45. IMAI T., HIESHIMA K., HASKELL C., BABA M., NAGIRA M., NISHIMURA M., KAKIZAKI M., TAKAGI S., NOMIYAMA H., SCHALL T. J. and YOSHIE O. (1997): Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell, 91, 521-530.
46. IMAI Y., LASKY L. A. and ROSEN S. D. (1992): Further characterization of the interaction between L-selectin and its endothelial ligands. Glycobiology, 2, 373-381.
47. IRIMURA T. and NICOLSON G. L. (1981): The role of glycoconjugates in metastatic melanoma blood-borne arrest and cell surface properties. J. Supramol. Struct. Cell Biochem., 17, 325- 336.
48. JAIN R. K. and PADERA T. P. (2002): Prevention and treatment of lymphatic metastasis by antilymphangiogenic therapy. J. Natl. Cancer Inst., 94, 785-787.
49. JALKANEN S., STEERE A. C., FOX R. I. and BUTCHER E. C. (1986): A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium. Science, 233, 556-558.
50. KALLMANN B. A., WAGNER S., HUMMEL V., BUTTMANN M., BAYAS A., TONN J. C. and RIECKMANN P. (2002): Characteristic gene expression profile of primary human cerebral endothelial cells. FASEB J. (in press).
51. KARKKAINEN M. J., MAKINEN T. and ALITALO K. (2002): Lymphatic endothelium: a new frontier of metastasis research. Nat. Cell Biol., 4, E2-5.
52. KELLERMANN S. A., HUDAK S., OLDHAM E. R., LIU Y. J. and MCEVOY L. M. (1999): The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3β are potent chemoattractants for in vitro- and in vivo-derived dendritic cells. J. Immunol., 162, 3859-3864.
53. KIEDA C. M., BOWLES D. J., RAVID A. and SHARON N. (1978): Lectins in lymphocyte membranes. FEBS Lett., 94, 391-396.
54. KIEDA C. and MONSIGNY M. (1986): Involvement of membrane sugar receptors and membrane glycoconjugates in the adhesion of 3LL cell subpopulations to cultured pulmonary cells. Invasion Metastasis, 6, 347-366.
55. KUNKEL E. J. and BUTCHER E. C. (2002): Chemokines and the tissue-specific migration of lymphocytes. Immunity, 16, 1-4.
56. LEY K., ZAKRZEWICZ A., HANSKI C., STOOLMAN L. M. and KANSAS G. S. (1995): Sialylated O-glycans and L-selectin sequentially mediate myeloid cell rolling in vivo. Blood, 85, 3727-3735.
57. LI L., SHORT H. J., QIAN K. X., ELHAMMER A. P. and GENG J. G. (2001): Characterization of glycoprotein ligands for P-selectin on a human small cell lung cancer cell line NCI-H345. Biochem. Biophys. Res. Commun., 288, 637-644.
58. LI Y., WANG M. N., LI H., KING K. D., BASSI R., SUN H., SANTIAGO A., HOOPER A. T., BOHLEN P. and HICKLIN D. J. (2002): Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis. J. Exp. Med., 195, 1575-1584.
59. LOTAN R., BELLONI P. N., TRESSLER R. J., LOTAN D., XU X. C. and NICOLSON G. L. (1994): Expression of galectins on microvessel endothelial cells and their involvement in tumour cell adhesion. Glycoconj. J., 11, 462-468.
60. MAEHARA Y., KABASHIMA A., KOGA T., TOKUNAGA E., TAKEUCHI H., KAKEJI Y. and SUGIMACHI K. (2000): Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma. Surgery, 128, 408-416.
61. MANNORI G., CROTTET P., CECCONI O., HANASAKI K., ARUFFO A., NELSON R. M., VARKI A. and BEVILACQUA M. P. (1995): Differential colon cancer cell adhesion to E-, P-, and L-selectin: role of mucin-type glycoproteins. Cancer Res., 55, 4425-4431.
62. MATSUSHITA Y., KITAJIMA S., GOTO M., TEZUKA Y., SAGARA M., IMAMURA H., TANABE G., TANAKA S., AIKOU T. and SATO E. (1998): Selectins induced by interleukin-1β on the human liver endothelial cells act as ligands for sialyl Lewis X-expressing human colon cancer cell metastasis. Cancer Lett., 133, 151-160.
63. MCEVER R. P. (1991): GMP-140: a receptor for neutrophils and monocytes on activated platelets and endothelium. J. Cell Biochem., 45, 156-161.
64. MEHTA P., CUMMINGS R. D. and MCEVER R. P. (1998): Affinity and kinetic analysis of P-selectin binding to P-selectin glycoprotein ligand-1. J. Biol. Chem., 273, 32506-32513.
65. MICHIE S. A., STREETER P. R., BOLT P. A., BUTCHER E. C. and PICKER L. J. (1993): The human peripheral lymph node vascular addressin. An inducible endothelial antigen involved in lymphocyte homing. Am. J. Pathol., 143, 1688-1698.
66. MICHIE S. A., STREETER P. R., BUTCHER E. C. and ROUSE R. V. (1995): L-selectin and α4 β7 integrin homing receptor pathways mediate peripheral lymphocyte traffic to AKR mouse hyperplastic thymus. Am. J. Pathol., 147, 412-421.
67. MOORE K. L. (1998): Structure and function of P-selectin glycoprotein ligand-1. Leuk. Lymphoma, 29, 1-15.
68. MORGAN S. M., SAMULOWITZ U., DARLEY L., SIMMONS D. L. and VESTWEBER D. (1999): Biochemical characterization and molecular cloning of a novel endothelial-specific sialomucin. Blood, 93, 165-175.
69. NAKACHE M., BERG E. L., STREETER P. R. and BUTCHER E. C. (1989): The mucosal vascular addressin is a tissue-specific endothelial cell adhesion molecule for circulating lymphocytes. Nature, 337, 179-181.
70. NANGIA-MAKKER P., BACCARINI S. and RAZ A. (2000): Carbohydrate-recognition and angiogenesis. Cancer Metastasis Rev., 19, 51-57.
71. NEMOTO Y., IZUMI Y., TEZUKA K., TAMATANI T. and IRIMURA T. (1998): Comparison of 16 human colon carcinoma cell lines for their expression of sialyl LeX antigens and their E-selectin-dependent adhesion. Clin. Exp. Metastasis, 16, 569-576.
72. NORMAN K. E., MOORE K. L., MCEVER R. P. and LEY K. (1995): Leukocyte rolling in vivo is mediated by P-selectin glycoprotein ligand-1. Blood, 86, 4417-4421.
73. OJEIFO J. O., LEE H. R., REZZA P., SU N. and ZWIEBEL J. A. (2001): Endothelial cell-based systemic gene therapy of metastatic melanoma. Cancer Gene Ther., 8, 636-648.
74. OPOLSKI A., WIETRZYK J., DUS D., KIEDA C., MATEJUK A., MAKOWSKA A., WOJDAT E., UGORSKI M., LASKOWSKA A., KLOPOCKI A., RYGAARD J. and RADZIKOWSKI C. (1998): Metastatic potential and saccharide antigens expression of human colon cancer cells xenotransplanted into athymic nude mice. Folia Microbiol., 43, 507-510.
75. PALS S. T., HORST E., SCHEPER R. J. and MEUER C. J. (1989): Mechanisms of human lymphocyte migration and their role in the pathogenesis of disease. Immunol. Rev., 108, 111-133.
76. PAULI B. U., AUGUSTIN-VOSS H. G., EL-SABBAN M. E., JOHNSON R. C. and HAMMER D. A. (1990): Organ-preference of metastasis. The role of endothelial cell adhesion molecules. Cancer Metastasis Rev., 9, 175-189.
77. PICKER L. J. and BUTCHER E. C. (1992): Physiological and molecular mechanisms of lymphocyte homing. Annu. Rev. Immunol., 10, 561-591.
78. PICKER L. J., KISHIMOTO T. K., SMITH C. W., WARNOCK R. A. and BUTCHER E. C. (1991): ELAM-1 is an adhesion molecule for skin-homing T cells. Nature, 349, 796-799.
79. PICKER L. J., NAKACHE M. and BUTCHER E. C. (1989): Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types. J. Cell Biol., 109, 927-937.
80. PILI R., CHANG J., PARTIS R. A., MUELLER R. A., CHREST F. J. and PASSANITI A. (1995): The α-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth. Cancer Res., 55, 2920- 2926.
81. POUYANI T. and SEED B. (1995): PSGL-1 recognition of P-selectin is controlled by a tyrosine sulfation consensus at the PSGL-1 amino terminus. Cell, 83, 333-343.
82. PURI K. D., FINGER E. B., GAUDERNACK G. and SPRINGER T. A. (1995): Sialomucin CD34 is the major L-selectin ligand in human tonsil high endothelial venules. J. Cell Biol., 131, 261-270.
83. SAIKI I., KOIKE C., OBATA A., FUJII H., MURATA J., KISO M., HASEGAWA A., KOMAZAWA H., TSUKADA H., AZUMA I., OKADA S. and OKU N. (1996): Functional role of sialyl Lewis X and fibronectin-derived RGDS peptide analogue on tumor-cell arrest in lungs followed by extravasation. Int. J. Cancer, 65, 833-839.
84. SASSETTI C., TANGEMANN K., SINGER M. S., KERSHAW D. B. and ROSEN S. D. (1998): Identification of podocalyxin-like protein as a high endothelial venule ligand for L-selectin: parallels to CD34. J. Exp. Med., 187, 1965-1975.
85. SASSETFI C., VAN ZANTE A. and ROSEN S. D. (2000): Identification of endoglycan, a member of the CD34/podocalyxin family of sialomucins. J. Biol. Chem., 275, 9001-9010.
86. SCHURMANN G. (1997): Cell adhesion. Molecular principles and initial implications for surgery. Chirurg, 68, 477-487.
87. SCOTT L. J., CLARKE N. W., GEORGE N. J., SHANKS J. H., TESTA N. G. and LANG S. H. (2001): Interactions of human prostatic epithelial cells with bone marrow endothelium: binding and invasion. Br. J. Cancer, 84, 1417-1423.
88. SEPPO A., TURUNEN J. P., PENTIILA L., KEANE A., RENKONEN O. and RENKONEN R. (1996): Synthesis of a tetravalent sialyl Lewis x glycan, a high-affinity inhibitor of L-selectin-mediated lymphocyte binding to endothelium. Glycobiology, 6, 65-71.
89. SHARMA S., STOLINA M., LUO J., STRIETER R. M., BURDICK M., ZHU L. X., BATRA R. K. and DUBINETT S. M. (2000): Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo. J. Immunol., 164, 4558-4563.
90. SHER B. T., BARGATZE R., HOLZMANN B., GALLATIN W. M., MATTHEWS D., WU N., PICKER L., BUTCHER E. C. and WEISSMAN I. L. (1988): Homing receptors and metastasis. Adv. Cancer Res., 51, 361-390.
91. SLATON J. W., INOUE K., PERROTTE P., EL-NAGGAR A. K., SWANSON D. A., FIDLER I. J. and DINNEY C. P. (2001): Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma. Am. J. Pathol., 158, 735-743.
92. SPRINGER T. A. (1990): Adhesion receptors of the immune system. Nature, 346, 425-434.
93. SPRINGER T. A. (1994): Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell, 76, 301-314.
94. STAROSELSKY A. N., MAHLIN T., SAVION N., KLEIN O., NORDENBERG J., DONIN N., MICHOWITZ M. and LEIBOVICI J. (1996): Metastatic potential and multidrug resistance correlation in the B16 melanoma system. J. Exp. Ther. Oncol., 1, 251-259.
95. ST CROIX B., RAGO C., VELCULESCU V., TRAVERSO G., ROMANS K. E., MONTGOMERY E., LAL A., RIGGINS G. J., LENGAUER C., VOGELSTEIN B. and KINZLER K. W. (2000): Genes expressed in human tumor endothelium. Science, 289, 1197-1202.
96. STEEBER D. A., TANG M. L., GREEN N. E., ZHANG X. Q., SLOANE J. E. and TEDDER T. F. (1999): Leukocyte entry into sites of inflammation requires overlapping interactions between the L-selectin and ICAM-1 pathways. J. Immunol., 163, 2176-2186.
97. STEEGMAIER M., LEVINOVITZ A., ISENMANN S., BORGES E., LENTER M., KOCHER H. P., KLEUSER B. and VESTWEBER D. (1995): The E-selectin-ligand ESL-1 is a variant of a receptor for fibroblast growth factor. Nature, 373, 615-620.
98. STEFFEN B. J., BREIER G., BUTCHER E. C., SCHULZ M. and ENGELHARDT B. (1996): ICAM-1, VCAM-1, and MAdCAM-1 are expressed on choroid plexus epithelium but not endothelium and mediate binding of lymphocytes in vitro. Am. J. Pathol., 148, 1819-1838.
99. STOOLMAN L. M., YEDNOCK T. A. and ROSEN S. D. (1987): Homing receptors on human and rodent lymphocytes - evidence for a conserved carbohydrate-binding specificity. Blood, 70, 1842-1850.
100. ST-PIERRE Y., AOUDJIT F., LALANCETTE M. and POTWOROWSKI E. F. (1999): Dissemination of T cell lymphoma to target organs: a post-homing event implicating ICAM-1 and matrix metalloproteinases. Leuk. Lymphoma, 34, 53-61.
101. STREETER P. R., BERG E. L., ROUSE B. T., BARGATZE R. F. and BUTCHER E. C. (1988): A tissue-specific endothelial cell molecule involved in lymphocyte homing. Nature, 331, 41-46.
102. STREETER P. R., ROUSE B. T. and BUTCHER E. C. (1988): Immunohistologic and functional characterization of a vascular addressin involved in lymphocyte homing into peripheral lymph nodes. J. Cell Biol., 107, 1853-1862.
103. TANAKA Y. (2000): Integrin activation by chemokines: relevance to inflammatory adhesion cascade during T cell migration. Histol. Histopathol., 15, 1169-1176.
104. Tu L., MURPHY P. G., LI X. and TEDDER T. F. (1999): L-selectin ligands expressed by human leukocytes are HECA-452 antibody-defined carbohydrate epitopes preferentially displayed by P-selectin glycoprotein ligand-1. J. Immunol., 163, 5070-5078.
105. VESTWEBER D. and BLANKS J. E. (1999): Mechanisms that regulate the function of the selectins and their ligands. Physiol. Rev., 79, 181-213.
106. VON ANDRIAN U. H., CHAMBERS J. D., BERG E. L., MICHIE S. A., BROWN D. A., KAROLAK D., RAMEZANI L., BERGER E. M., ARFORS K. E. and BUTCHER E. C. (1993): L-selectin mediates neutrophil rolling in inflamed venules through sialyl Lewis X-dependent and -independent recognition pathways. Blood, 82, 182-191.
107. WANG F., WEI L. and CHEN L. (2000): The relationship between vascular endothelial growth factor, microvascular density, lymph node metastasis and prognosis of breast carcinoma. Zhonghua Bing Li Xue Za Zhi, 29, 172-175.
108. WARDLAW A. J. (2001): Eosinophil trafficking in asthma. Clin. Med., 1, 214-218.
109. WARNOCK R. A., ASKARI S., BUTCHER E. C. and VON ANDRIAN U. H. (1998): Molecular mechanisms of lymphocyte homing to peripheral lymph nodes. J. Exp. Med., 187, 205-216.
110. WARNOCK R. A., CAMPBELL J. J., DORF M. E., MATSUZAWA A., MCEVOY L. M. and BUTCHER E. C. (2000): The role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer's patch high endothelial venules. J. Exp. Med., 191, 77-88.
111. WEI Y. Q., WANG Q. R., ZHAO X., YANG L., TIAN L., LU Y., KANG B., LU C. J., HUANG M. J., LOU Y. Y., XIAO F., HE Q. M., SHU J. M., XIE X. J., MAO Y. Q., LEI S., LUO F., ZHOU L. Q., LIU C. E., ZHOU H., JIANG Y., PENG F., YUAN L. P., LI Q., WU Y. and LIU J. Y. (2000): Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nat. Med., 6, 1160-1166.
112. WELPLY J. K., ABBAS S. Z., SCUDDER P., KEENE J. L., BROSCHAT K., CASNOCHA S., GORKA C., STEININGER C., HOWARD S. C., SCHMUKE J. J. et al. (1994): Multivalent sialyl-LeX: potent inhibitors of E-selectin-mediated cell adhesion; reagent for staining activated endothelial cells. Glycobiology, 4, 259-265.
113. WIDMER M. B., MORRISSEY P. J., GOODWIN R. G., GRABSTEIN K. H., PARK L. S., WATSON J. D., KINCADE P. W., CONLON P. J. and NAMEN A. E. (1990): Lymphopoiesis and IL-7. Int. J. Cell. Cloning, 8 (suppl. 1), 168-170; discussion 171-172.
114. WOYNAROWSKA B., DIMITROFF C. J., SHARMA M., MATTA K. L. and BERNACKI R. J. (1996): Inhibition of human HT-29 colon carcinoma cell adhesion by a 4-fluoro-glucosamine analogue. Glycoconj. J., 13, 663-674.
115. YANG R. B., NG C. K., WASSERMAN S. M., COLMAN S. D., SHENOY S., MEHRABAN F., KOMUVES L. G., TOMLINSON J. E. and TOPPER J. N. (2002): Identification of a novel family of cell-surface proteins expressed in human vascular endothelium. J. Biol. Chem., 21, 21.
116. YEDNOCK T. A., BUTCHER E. C., STOOLMAN L. M. and ROSEN S. D. (1987): Receptors involved in lymphocyte homing: relationship between a carbohydrate-binding receptor and the MEL-14 antigen. J. Cell Biol., 104, 725-731.
117. YOSHIDA H., HONDA K., SHINKURA R., ADACHI S., NISHIKAWA S., MAKI K., IKUTA K. and NISHIKAWA S. I. (1999): IL-7 receptor α(+) CD3(-) cells in the embryonic intestine induces the organizing center of Peyer's patches. Int. Immunol., 11, 643-655.
118. ZEISIG R., STAHN R. and FICHTNER I. (2002): Inhibition of carbohydrate mediated cell adhesion by liposomes as a possible way to prevent tumour metastasis. Cell. Mol. Biol. Lett., 7, 270-271.
119. ZHANG L., UNDERHILL C. B. and CHEN L. (1995): Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res., 55, 428-433.
120. ZHU D. Z., CHENG C. F. and PAULI B. U. (1991): Mediation of lung metastasis of murine melanomas by a lung-specific endothelial cell adhesion molecule. Proc. Natl. Acad. Sci. USA, 88, 9568-9572.
121. ZOLL B., LEFTEROVA P., CSIPAI M., FINKE S., TROJANECK B., EBERT O., MICKA B., ROIGK K., FEHLINGER M., SCHMIDT-WOLF G. D., HUHN D. and SCHMIDT-WOLF I. G. (1998): Generation of cytokine-induced killer cells using exogenous interleukin-2, -7 or -12. Cancer Immunol. Immunother., 47, 221-226.
122. ZOLLNER O. and VESTWEBER D. (1996): The E-selectin ligand-1 is selectively activated in Chinese hamster ovary cells by the α(1,3)-fucosyltransferases IV and VII. J. Biol. Chem., 271, 33002-33008.